Finance

Lists
F6T:FRA
Fate Therapeutics Inc
€2.13
+2.40%
(+0.050) 1D
Sep 18, 8:16:50 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for F6T...
Open
€2.13
High
€2.13
Low
€2.13
Mkt. cap
300.15M
Avg. vol.
5.00
Volume
0.00
52-wk high
€2.67
52-wk low
€0.79
No. of employees
161
Open
€2.13
High
€2.13
Low
€2.13
Mkt. cap
300.15M
Avg. vol.
5.00
Volume
0.00
52-wk high
€2.67
52-wk low
€0.79
No. of employees
161
News stories
From web sources and news partners
About Fate Therapeutics Inc
CEOScott Wolchko
Employees161
Founded2007
Headquarters-
SectorBiotechnology
Websitefatetherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.74M
1.37M
1.30M
2.08M
Cost of goods sold
25.84M
9.50M
24.70M
24.39M
Cost of revenue
25.84M
9.50M
24.70M
24.39M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.64M
25.50M
9.60M
8.83M
Operating expense
10.64M
25.50M
9.60M
8.83M
Total operating expenses
36.48M
34.99M
34.30M
33.22M
Operating income
-34.74M
-33.62M
-33.00M
-31.13M
Other non operating income
-90.00K
127.00K
-80.00K
-580.00K
EBT including unusual items
-32.25M
-32.37M
-31.21M
-30.16M
EBT excluding unusual items
-32.25M
-31.27M
-31.21M
-30.16M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-32.25M
-32.37M
-31.21M
-30.16M
Net profit margin
-1,852.38%
-2,364.79%
-2,402.85%
-1,448.56%
Earnings per share
-0.27
-0.27
-0.26
-0.25
Interest and investment income
2.58M
2.22M
1.87M
1.56M
Interest expense
-
-
-
-
Net interest expenses
2.58M
2.22M
1.87M
1.56M
Depreciation and amortization charges
-
-
-
-
EBITDA
-31.51M
-30.56M
-30.08M
-28.35M
Gain or loss from assets sale
-
45.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps